The effect of omega-3 fatty acids on serum paraoxonase activity, vitamins a, e, and c in type 2 diabetic patients

Journal of Research in Medical Sciences

Volumn 16, Issue 7, 2011, Pages 878-884

  Kouchak, Anis ^a   Djalali, Mahmoud ^a   Eshraghian, Mohamadreza ^a   Saedisomeolia, Ahmad ^a   Djazayery, Abolghassem ^a   Hajianfar, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Paraoxonase; Vitamin A; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE; ASCORBIC ACID; GLUCOSE; OMEGA 3 FATTY ACID; PLACEBO; RETINOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRIENT UPTAKE; NUTRITIONAL ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SPECTROPHOTOMETRY; TREATMENT DURATION; VITAMIN BLOOD LEVEL;

EID: 80052894096     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Canepa ET, Llambias EB, Grinstein M. Studies on regulatory mechanisms of heme biosynthesis in hepatocytes from normal and experimental-diabetic rats. Role of insulin. Biochem Cell Biol 1990; 68(6): 914-921.
2. Reusch JE. Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose? J Clin Invest 2003; 112(7): 986-988.
3. Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW, et al. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus. Eur J Clin Invest 2003; 33(3): 231-238.
4. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with Type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest 2007; 30(10): 833-838.
5. Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, et al. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008; 52(12): 988-996.
6. Valiyaveettil M, Alamneh Y, Biggemann L, Soojhawon I, Farag HA, Agrawal P, et al. In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates. Toxicol In Vitro 2011; 25(4): 905-913.
7. Hassett C, Richter RJ, Humbert R, Chapline C, Crabb JW, Omiecinski CJ, et al. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 1991; 30(42): 10141-10149.
8. Costa LG, Cole TB, Jarvik GP, Furlong CE. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 2003; 54: 371-392.
9. Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001; 21(4): 473-480.
10. Karabina SA, Lehner AN, Frank E, Parthasarathy S, Santanam N. Oxidative inactivation of paraoxonase--implications in diabetes mellitus and atherosclerosis. Biochim Biophys Acta 2005; 1725(2): 213-221.
11. Mackness MI, Durrington PN, Mackness B. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention. Am J Cardiovasc Drugs 2004; 4(4): 211-217.
12. Lai MH. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus. J Clin Biochem Nutr 2008; 43(3): 191-198.
13. Riccioni G, Bucciarelli T, Mancini B, Di IC, Capra V, D'Orazio N. The role of the antioxidant vitamin supplementation in the prevention of cardiovascular diseases. Expert Opin Investig Drugs 2007; 16(1): 25-32.
14. Dorchy H. Lower plasma vitamin C levels in young type I diabetic patients with microalbuminuria. J Diabetes Complications 1999; 13(2): 119.
15. Takahashi N, Morimoto S, Okigaki M, Seo M, Someya K, Morita T, et al. Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients. Nephrol Dial Transplant 2011; 26(4): 1252-7.
16. Dobrucki R, Radomska A. Retinol palmitate as a model substance to test antioxidant properties in vitro on the example of captopril. Pharmazie 2002; 57(9): 635-637.
17. Tesoriere L, D'Arpa D, Re R, Livrea MA. Antioxidant reactions of all-trans retinol in phospholipid bilayers: effect of oxygen partial pressure, radical fluxes, and retinol concentration. Arch Biochem Biophys 1997; 343(1): 13-18.
18. Johnson AT, Kretzer FL. Interstitial retinol binding protein in the developing human retina: a proposed explanation for vitamin E suppression of retinopathy of prematurity. Prog Clin Biol Res 1985; 190: 251-277.
19. Shirpoor A, Ilkhanizadeh B, Saadatian R, Darvari BS, Behtaj F, Karimipour M, et al. Effect of vitamin E on diabetes-induced changes in small intestine and plasma antioxidant capacity in rat. J Physiol Biochem 2006; 62(3): 171-177.
20. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am J Med 2002; 112(4): 298-304.
21. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003; 107(14): 1852-1857.
22. Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol 2008; 42(4): 413-418.
23. Carmeli E, Coleman R, Berner YN. Activities of antioxidant scavenger enzymes (superoxide dismutase and glutathione peroxidase) in erythrocytes in adult women with and without type II diabetes. Exp Diabesity Res 2004; 5(2): 171-175.
24. Song SH, Hardisty CA. Early-onset Type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk. Expert Rev Cardiovasc Ther 2008; 6(3): 315-322.
25. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, et al. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 2000; 275(23): 17527-17535.
26. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91(9): 2488-2496.
27. Calder PC, Yaqoob P. Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell Mol Biol (Noisy-le-grand) 2010; 56(1): 28-37.
28. Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005; 111(2): 157-64.
29. Saedisomeolia A, Wood LG, Garg ML, Gibson PG, Wark PA. Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells. Br J Nutr 2009; 101(4): 533-540.
30. Saedisomeolia A, Wood LG, Garg ML, Gibson PG, Wark PA. Supplementation of long chain N-3 polyunsaturated fatty acidsincrease the utilization oflycopene in cultured airway epithelial cells. Journal of Food Lipids 2008; 15(4): 421-432.
31. Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, et al. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism 2004; 53(2): 153-158.
32. Maritim AC, Sanders RA, Watkins JB, III. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17(1): 24-38.
33. Chen MS, Hutchinson ML, Pecoraro RE, Lee WY, Labbe RF. Hyperglycemia-induced intracellular depletion of ascorbic acid in human mononuclear leukocytes. Diabetes 1983; 32(11): 1078-1081.
34. Dyer RG, Stewart MW, Mitcheson J, George K, Alberti MM, Laker MF. 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease. Clin Chim Acta 1997; 260(1): 1-13.
35. Merzouk S, Hichami A, Madani S, Merzouk H, Berrouiguet AY, Prost J, et al. Antioxidant status and levels of different vitamins determined by high performance liquid chromatography in diabetic subjects with multiple complications. Gen Physiol Biophys 2003; 22(1): 15-27.
36. Salonen JT, Nyyssonen K, Tuomainen TP, Maenpaa PH, Korpela H, Kaplan GA, et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 1995; 311(7013): 1124-7.
37. Yamada H, Yamada K, Waki M, Umegaki K. Lymphocyte and plasma vitamin C levels in type 2 diabetic patients with and without diabetes complications. Diabetes Care 2004; 27(10): 2491-2.
38. Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996; 90(4): 255-60.
39. Basu TK, Tze WJ, Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 1989; 50(2): 329-31.
40. Zhou D, Ghebremeskel K, Crawford MA, Reifen R. Vitamin A deficiency enhances docosahexaenoic and osbond acids in liver of rats fed an alpha linolenic acid-adequate diet. Lipids 2006; 41(3): 213-9.
41. Zhou D, Zaiger G, Ghebremeskel K, Crawford MA, Reifen R. Vitamin A deficiency reduces liver and colon docosahexaenoic acid levels in rats fed high linoleic and low alpha-linolenic acid diet. Prostaglandins Leukot Essent Fatty Acids 2004; 71(6): 383-9.